Khandan Baradaran
Vice President
Head of Regulatory and Quality Assurance
Dimension Therapeutics
United States of America
Biography
Dr. Baradaran received her B.A degree in Molecular Biology from Wellesley College and her Ph.D. in Virology from Harvard University.Khandan Baradaran, Ph.D. is Vice President of Regulatory Affairs and Quality Assurance at Dimension Therapeutics. Dr. Baradaran has extensive expertise in the areas of viral safety, gene therapy vector development, vaccine development and assay technologies.She has held positions of increasing responsibility in Regulatory Affairs, Quality Control and Quality Assurance, most recently at Shire Pharmaceuticals where she was responsible for early and late stage rare disease development programs utilizing novel medical device and gene therapy approaches. Before joining Shire Dr. Baradaran was at Biogen where she was the Global Regulatory lead for AVONEX,and MS drug that is marketed in over 100 countries. Dr. Baradaran received her B.A degree in Molecular Biology from Wellesley College and her Ph.D. in Virology from Harvard University.Khandan Baradaran, Ph.D. is Vice President of Regulatory Affairs and Quality Assurance at Dimension Therapeutics. Dr. Baradaran has extensive expertise in the areas of viral safety, gene therapy vector development, vaccine development and assay technologies.She has held positions of increasing responsibility in Regulatory Affairs, Quality Control and Quality Assurance, most recently at Shire Pharmaceuticals where she was responsible for early and late stage rare disease development programs utilizing novel medical device and gene therapy approaches. Before joining Shire Dr. Baradaran was at Biogen where she was the Global Regulatory lead for AVONEX,and MS drug that is marketed in over 100 countries.
Research Interest
His research interest in Business and Management
